| 来源类型 | Working Paper |
| 规范类型 | 报告 |
| DOI | 10.3386/w28395 |
| 来源ID | Working Paper 28395 |
| The Economic Case for Global Vaccinations: An Epidemiological Model with International Production Networks | |
| Cem Çakmaklı; Selva Demiralp; Ṣebnem Kalemli-Özcan; Sevcan Yeşiltaş; Muhammed A. Yıldırım | |
| 发表日期 | 2021-01-25 |
| 出版年 | 2021 |
| 语种 | 英语 |
| 摘要 | COVID-19 pandemic had a devastating effect on both lives and livelihoods in 2020. The arrival of effective vaccines can be a major game changer. However, vaccines are in short supply as of early 2021 and most of them are reserved for the advanced economies. We show that the global GDP loss of not inoculating all the countries, relative to a counterfactual of global vaccinations, can be higher than the cost of manufacturing and distributing vaccines globally. We use an economic-epidemiological framework that combines a SIR model with international production and trade networks. Based on this framework, we estimate the costs for 65 countries and 35 sectors. Our estimates suggest that up to 49 percent of the global economic costs of the pandemic in 2021 are borne by the advanced economies even if they achieve universal vaccination in their own countries. |
| 主题 | International Economics ; Trade ; International Factor Mobility ; COVID-19 |
| URL | https://www.nber.org/papers/w28395 |
| 来源智库 | National Bureau of Economic Research (United States) |
| 引用统计 | |
| 资源类型 | 智库出版物 |
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/586069 |
| 推荐引用方式 GB/T 7714 | Cem Çakmaklı,Selva Demiralp,Ṣebnem Kalemli-Özcan,et al. The Economic Case for Global Vaccinations: An Epidemiological Model with International Production Networks. 2021. |
| 条目包含的文件 | ||||||
| 文件名称/大小 | 资源类型 | 版本类型 | 开放类型 | 使用许可 | ||
| w28395.pdf（6127KB） | 智库出版物 | 限制开放 | CC BY-NC-SA | 浏览 | ||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
